Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Reviva Pharmaceuticals Holdings, Inc. (TZACU) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Reviva Pharmaceuticals Holdings, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1742927.
Total stock buying since 2018: $15,538,919.
Total stock sales since 2018: $6,765,791.
Total stock option exercises since 2018: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 103,000 | $157,720 | 0 | $0 | 0 | $0 |
| 2021 | 1,330,000 | $4,987,500 | 0 | $0 | 0 | $0 |
| 2020 | 10,000 | $103,699 | 620,260 | $6,765,791 | 0 | $0 |
| 2018 | 1,029,000 | $10,290,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-11 | 3,000 | $14,070 | 0 | $0 | 0 | $0 |
| 2022-09 | 50,000 | $83,000 | 0 | $0 | 0 | $0 |
| 2022-06 | 50,000 | $60,650 | 0 | $0 | 0 | $0 |
| 2021-06 | 1,330,000 | $4,987,500 | 0 | $0 | 0 | $0 |
| 2020-12 | 0 | $0 | 422,623 | $4,630,313 | 0 | $0 |
| 2020-11 | 0 | $0 | 145,634 | $1,583,025 | 0 | $0 |
| 2020-09 | 0 | $0 | 1,003 | $10,833 | 0 | $0 |
| 2020-05 | 0 | $0 | 51,000 | $541,620 | 0 | $0 |
| 2020-03 | 10,000 | $103,699 | 0 | $0 | 0 | $0 |
| 2018-08 | 1,029,000 | $10,290,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-11-18 | Patel Purav (Director) | Buy | 3,000 | 4.69 | 14,070 |
| 2022-09-30 | Narayan Prabhu (Chief Financial Officer) | Buy | 50,000 | 1.66 | 83,000 |
| 2022-06-30 | Narayan Prabhu (Chief Financial Officer) | Buy | 50,000 | 1.21 | 60,650 |
| 2021-06-01 | Saxena Parag (Director) | Buy | 1,330,000 | 3.75 | 4,987,500 |
| 2020-12-08 | Glazer Paul J (10% Owner) | Sale | 367,000 | 10.88 | 3,992,960 |
| 2020-12-07 | Gerber Sander (10% Owner) | Sale | 50,000 | 11.51 | 575,500 |
| 2020-12-02 | Glazer Paul J (10% Owner) | Sale | 261 | 11.00 | 2,871 |
| 2020-12-01 | Glazer Paul J (10% Owner) | Sale | 5,362 | 11.00 | 58,982 |
| 2020-11-27 | Glazer Paul J (10% Owner) | Sale | 5,969 | 10.90 | 65,062 |
| 2020-11-24 | Glazer Paul J (10% Owner) | Sale | 7,103 | 10.90 | 77,422 |
| 2020-11-23 | Glazer Paul J (10% Owner) | Sale | 23,611 | 10.90 | 257,359 |
| 2020-11-18 | Glazer Paul J (10% Owner) | Sale | 896 | 10.90 | 9,766 |
| 2020-11-17 | Glazer Paul J (10% Owner) | Sale | 127 | 10.90 | 1,384 |
| 2020-11-16 | Glazer Paul J (10% Owner) | Sale | 305 | 10.90 | 3,324 |
| 2020-11-11 | Glazer Paul J (10% Owner) | Sale | 5 | 10.90 | 54 |
| 2020-11-06 | Glazer Paul J (10% Owner) | Sale | 1 | 10.90 | 10 |
| 2020-11-03 | Glazer Paul J (10% Owner) | Sale | 57,616 | 10.85 | 625,133 |
| 2020-11-02 | Gerber Sander (10% Owner) | Sale | 50,000 | 10.87 | 543,500 |
| 2020-11-02 | Glazer Paul J (10% Owner) | Sale | 1 | 11.50 | 11 |
| 2020-09-29 | Glazer Paul J (10% Owner) | Sale | 2 | 11.50 | 23 |
| 2020-09-17 | Glazer Paul J (10% Owner) | Sale | 1,000 | 10.80 | 10,800 |
| 2020-09-14 | Glazer Paul J (10% Owner) | Sale | 1 | 10.80 | 10 |
| 2020-05-08 | Mizuho Securities Usa Llc (10% Owner) | Sale | 51,000 | 10.62 | 541,620 |
| 2020-03-20 | Gerber Sander (10% Owner) | Buy | 10,000 | 10.37 | 103,699 |
| 2018-08-30 | Tenzing Llc | Buy | 33,000 | 10.00 | 330,000 |
| 2018-08-30 | Nayar Rahul (Chief Executive Officer) | Buy | 33,000 | 10.00 | 330,000 |
| 2018-08-30 | Saxena Parag (Chairman of the Board) | Buy | 33,000 | 10.00 | 330,000 |
| 2018-08-23 | Tenzing Llc | Buy | 310,000 | 10.00 | 3,100,000 |
| 2018-08-23 | Nayar Rahul (Chief Executive Officer) | Buy | 310,000 | 10.00 | 3,100,000 |
| 2018-08-23 | Saxena Parag (Chairman of the Board) | Buy | 310,000 | 10.00 | 3,100,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of TZACU listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Reviva Pharmaceuticals Holdings, Inc. (symbol TZACU, CIK number 1742927) see the Securities and Exchange Commission (SEC) website.